Category:
API Equipment
Standard:
N;
China GMP
Form: capsule
Strength: 50mg
Indication: The drug is indicated for the treatment of acute or chronic hepatitis with ALT increase.
This category refers to Diammonium glycyrrhizinate enteric capsules, a pharmaceutical formulation designed for targeted delivery. Manufactured under strict GMP standards, the core material utilizes an acid-resistant coating to ensure stability in gastric environments while facilitating release in the intestines.
Storage requires cool, dry conditions below 25°C to maintain capsule integrity. Production lines must enforce rigorous moisture control during encapsulation. Periodic replacement of sealing equipment is recommended every six months to prevent cross-contamination and ensure dosage accuracy.